“Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration,” the AP reports.
Washington Post: “The administration’s approval of the drug on Tuesday comes less than two weeks after Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Martin Makary said the department was conducting a review of the safety of abortion pills, a decision that antiabortion activists welcomed.”
“Now, those same leaders are questioning the administration’s commitment to their cause, marking the first significant pushback Trump has received from his otherwise loyal base of socially conservative activists.”
Save to Favorites